New research shows that the asthma drug benralizumab failed to decrease annual COPD exacerbation rates for patients with moderate to very severe COPD, a history of frequent moderate and/or severe exacerbations, and eosinophilic inflammation.
An app that allows parents and doctors to monitor a child’s asthma has a big impact on managing the disease. When families monitored symptoms with eAsthma Tracker and adjusted care accordingly, children had better asthma control and made fewer visits to the...
A new review of studies on levels of urban exposure to airborne pollutants and their effects on human health suggests that advanced instrumentation and information technology will soon allow researchers and policymakers to gauge the health risks of air pollution on an...
In the first study to evaluate inhaler technique in children hospitalized for asthma — the group at highest risk for complications and death from asthma — researchers found that nearly half of participants demonstrated improper inhaler use, which means...
RSS Error: A feed could not be found at `http://www.scoop.it/t/pulmonaryrehabnews/rss.xml`; the status code is `404` and content-type is `text/html;charset=UTF-8`
